<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinvest</journal-id><journal-title-group><journal-title xml:lang="ru">Качественная клиническая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0519</issn><issn pub-type="epub">2618-8473</issn><publisher><publisher-name>ООО «Издательство ОКИ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">clinvest-251</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАЧЕСТВО ЖИЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>QUALITY OF LIFE</subject></subj-group></article-categories><title-group><article-title>Оценка качества жизни при различных сердечно-сосудистых заболеваниях</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мясоедова</surname><given-names>Н. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><email xlink:type="simple">clinvest@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тхостова</surname><given-names>Э. Б.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><email xlink:type="simple">clinvest@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоусов</surname><given-names>Ю. Б.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><email xlink:type="simple">clinvest@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Российский государственный медицинский университет, Москва</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Российский государственный медицинский университет, г. Москва</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>ГОУ ВПО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова», Москва</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2002</year></pub-date><pub-date pub-type="epub"><day>23</day><month>06</month><year>2008</year></pub-date><volume>0</volume><issue>1</issue><fpage>53</fpage><lpage>57</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мясоедова Н.А., Тхостова Э.Б., Белоусов Ю.Б., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Мясоедова Н.А., Тхостова Э.Б., Белоусов Ю.Б.</copyright-holder><copyright-holder xml:lang="en">Мясоедова Н.А., Тхостова Э.Б., Белоусов Ю.Б.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinvest.ru/jour/article/view/251">https://www.clinvest.ru/jour/article/view/251</self-uri><abstract><p>Различные заболевания влияют не только на физическое состояние человека, но и на психологию его поведения, эмоциональные реакции, а также изменяют его место и роль в социальной жизни. Чаще всего в поле зрения врача оказываются физикальные, лабораторные и инструментальные данные, описывающие состояние больного. Информация о психологических и социальных проблемах, появившихся в жизни человека в связи с болезнью, как правило, мало доступна врачу. Одним из новых критериев оценки эффективности оказания медицинской помощи, получивших в последние годы, является качество жизни (КЖ).</p><p>Качество жизни, по определению ВОЗ, - это характеристика физического, психологического, эмоционального и социального функционирования, основанная на его субъективном восприятии.</p><p>В современной зарубежной медицинской литературе широко распространен термин 'качество жизни, обусловленное здоровьем' (Health-related Quality of life). КЖ, обусловленное здоровьем, оценивает компоненты, ассоциированные и неассоциированные с заболеванием, и позволяетдифференцированно определить влияние болезни и лечения на психологическое, эмоциональное состояние больного, его социальный статус.</p></abstract><kwd-group xml:lang="ru"><kwd>оценка качества жизни</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>QALY</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Quality of life group. What is it Quality of life? Wid. Hth. Forum. -1996. V.1.-P.29</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Quality of life group. What is it Quality of life? Wid. Hth. Forum. -1996. V.1.-P.29</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Measurement of level of health: Report of study group // WHO Technical Report Series.- 1957. R137</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Measurement of level of health: Report of study group // WHO Technical Report Series.- 1957. R137</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bullinger M. et al. Translating health study questionnaires and evaluating them: the Quality of life a project approach. International of Quality of life assessment // Clin. Epidemiol. -1998.- V.51.-P 913-923.</mixed-citation><mixed-citation xml:lang="en">Bullinger M. et al. Translating health study questionnaires and evaluating them: the Quality of life a project approach. International of Quality of life assessment // Clin. Epidemiol. -1998.- V.51.-P 913-923.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bowling A., Bond M., Jenkinson C., Lamping D.L. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between lhe norms provided by the Omnibus Survey in Britain, the Health Survey for England and Oxford Healthy Life Survey.// Journal of Public Health Medicine- 1999-Vol. 21, № 3.-R 255-70.</mixed-citation><mixed-citation xml:lang="en">Bowling A., Bond M., Jenkinson C., Lamping D.L. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between lhe norms provided by the Omnibus Survey in Britain, the Health Survey for England and Oxford Healthy Life Survey.// Journal of Public Health Medicine- 1999-Vol. 21, № 3.-R 255-70.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Beusterien K.M., Steinwald В., Ware J.E. Jr. Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly// Journal of Oeriatric Psychiatry and Neurology - 1996 Jan. -Vol.9 -№1. -P13-21.</mixed-citation><mixed-citation xml:lang="en">Beusterien K.M., Steinwald В., Ware J.E. Jr. Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly// Journal of Oeriatric Psychiatry and Neurology - 1996 Jan. -Vol.9 -№1. -P13-21.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gabriel S.E., Kneeland T.S., Melton L.J. Health-related quality of life in economic evaluations for osteoporosis: worse values should we use? // Medical Decision Making - 1999 Apr-Jun., - Vol. №19. - P. 141-8.</mixed-citation><mixed-citation xml:lang="en">Gabriel S.E., Kneeland T.S., Melton L.J. Health-related quality of life in economic evaluations for osteoporosis: worse values should we use? // Medical Decision Making - 1999 Apr-Jun., - Vol. №19. - P. 141-8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">E.A. Максимкина, Е.Е.Лоскутова, В.В. Дорофеева 'Конкурентоспособность фармацевтической организации в условиях рынка', Москва, 1999, 198-199</mixed-citation><mixed-citation xml:lang="en">E.A. Максимкина, Е.Е.Лоскутова, В.В. Дорофеева 'Конкурентоспособность фармацевтической организации в условиях рынка', Москва, 1999, 198-199</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Norman M. et al. 'Clinical Hypertension' 7th ed.Chap.5, 149-150.</mixed-citation><mixed-citation xml:lang="en">Norman M. et al. 'Clinical Hypertension' 7th ed.Chap.5, 149-150.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">'The economics of hypertension control: some basic issues' J. of Human Hypertens 1992; 6:417-420 Modified from Maynard</mixed-citation><mixed-citation xml:lang="en">'The economics of hypertension control: some basic issues' J. of Human Hypertens 1992; 6:417-420 Modified from Maynard</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">J.Hosie and 1. Wlklund. Managing hypertension in general practice: can we do better? J. of Human Hypertension-1995, 9, S15-S18.</mixed-citation><mixed-citation xml:lang="en">J.Hosie and 1. Wlklund. Managing hypertension in general practice: can we do better? J. of Human Hypertension-1995, 9, S15-S18.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Isabelle Cote, Jean-Pieree Gregorie and Jocelyne Moisan, Health-Related Quality-of-Life measurement in Hypertension. A Review ofrandomized controlled drug trials // Pharmacoeconomics 2000 Now, 18 (5) 435-450.</mixed-citation><mixed-citation xml:lang="en">Isabelle Cote, Jean-Pieree Gregorie and Jocelyne Moisan, Health-Related Quality-of-Life measurement in Hypertension. A Review ofrandomized controlled drug trials // Pharmacoeconomics 2000 Now, 18 (5) 435-450.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Plaisted C.L., Lin P.H. et al. The effect of dietary patterns on quality of life: A substudy of Dietary Approaches to Stop Hypertension trial // J-AM-DTET-ASSOC- 1999,- Vol. 99, № 8 Suppl. - P. 84-89.</mixed-citation><mixed-citation xml:lang="en">Plaisted C.L., Lin P.H. et al. The effect of dietary patterns on quality of life: A substudy of Dietary Approaches to Stop Hypertension trial // J-AM-DTET-ASSOC- 1999,- Vol. 99, № 8 Suppl. - P. 84-89.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Levis C.E., Grandits A., Flack J., McDonald R., Elmer P.J. Efficacy and tolerance ofantihypertensive treatment in men and women with stage I diastolic hypertension. Results of the Treatment of Mild Hypertension Study. // Archives of Internal Medicine - 1996 Feb 26, Vol. 156, № 4, P- 377-85.</mixed-citation><mixed-citation xml:lang="en">Levis C.E., Grandits A., Flack J., McDonald R., Elmer P.J. Efficacy and tolerance ofantihypertensive treatment in men and women with stage I diastolic hypertension. Results of the Treatment of Mild Hypertension Study. // Archives of Internal Medicine - 1996 Feb 26, Vol. 156, № 4, P- 377-85.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Grimm R.H. Jr., Grands G.A., Cutler J.A., Stewart A.L. et al.. Relationships of quality of life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study // Archives of internal Medicine - 1997 Mar. 24, Vol-157, № 6, p-638-48.</mixed-citation><mixed-citation xml:lang="en">Grimm R.H. Jr., Grands G.A., Cutler J.A., Stewart A.L. et al.. Relationships of quality of life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study // Archives of internal Medicine - 1997 Mar. 24, Vol-157, № 6, p-638-48.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wlklund I., Hailing К., Ryden-Bergsten Т., FletcherA., Does lowering the blood pressure improves the mood? Quality of life results from the Hypertension Optimal Treatment (HOT) study. // Blood Pressure -1997 Nov., -Vol. 6, № 6, - P. 357-64.</mixed-citation><mixed-citation xml:lang="en">Wlklund I., Hailing К., Ryden-Bergsten Т., FletcherA., Does lowering the blood pressure improves the mood? Quality of life results from the Hypertension Optimal Treatment (HOT) study. // Blood Pressure -1997 Nov., -Vol. 6, № 6, - P. 357-64.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Agevall S, Wllkstrand J, Fagdeberg B. Stroke was predicted by dimensions of quality of life in treated hypertensive men. Stroke 1998, Nov; 29(11): 2329-33</mixed-citation><mixed-citation xml:lang="en">Agevall S, Wllkstrand J, Fagdeberg B. Stroke was predicted by dimensions of quality of life in treated hypertensive men. Stroke 1998, Nov; 29(11): 2329-33</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Jachuck SJ, Briely H, Jachuck S et al. 'The effect of hypotensive drugs on the quality of life' J R Coil. Gen Pract 1982, 32: 103-105.</mixed-citation><mixed-citation xml:lang="en">Jachuck SJ, Briely H, Jachuck S et al. 'The effect of hypotensive drugs on the quality of life' J R Coil. Gen Pract 1982, 32: 103-105.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
